11.07.2015 Views

Clinician's Pocket Drug Reference 2008

Clinician's Pocket Drug Reference 2008

Clinician's Pocket Drug Reference 2008

SHOW MORE
SHOW LESS

You also want an ePaper? Increase the reach of your titles

YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.

210 ValsartanLevels: Trough: just before next dose; Therapeutic: Peak 50–100 mcg/mL; ToxicTrough > 100 mcg/mL; 1 ⁄2 life: 5–20 h; phenobarbital & phenytoin may alter levelsValsartan (Diovan) WARNING: Use during 2nd/3rd tri of PRG can causefetal harm Uses: HTN, CHF, DN Action: Angiotensin II receptor antagonistDose: 80–160 mg/d, max 320 mg/day Caution: [C (1st tri; D 2nd & 3rd tri), ?/–]w/ K + -sparing diuretics or K + supls Contra: Severe hepatic impair, biliary cirrhosis/obst,primary hyperaldosteronism, bilateral RAS Disp: Tabs 40, 80, 160, 320mg, capsule: 80 mg, 160 mg SE: ↓ BP, dizzinessVancomycin (Vancocin, Vancoled) Uses: *Serious MRSA Infxns;enterococcal Infxns; PO Rx of C. difficile pseudomembranous colitis* Action:↓ Cell wall synth. Spectrum: Gram(+) bacteria & some anaerobes (includesMRSA, Staphylococcus sp, Enterococcus sp, Streptococcus sp, C. difficile) Dose:Adults. 1 g IV q12h; or 15 mg/kg/dose for colitis 125–500 mg PO q6h. Peds.40–60 mg/kg/24 h IV in ÷ doses q6–12 h. Neonates. 10–15 mg/kg/dose q12h; ↓ inrenal insuff Caution: [C, M] Contra: Component allergy; w/ avoid in Hx hearingloss Disp: Caps 125, 250 mg; powder 250 mg/5 mL, 500 mg/6 mL for PO soln;powder for inj 500 mg, 1000 mg, 10 g/vial SE: Ototoxic & nephrotoxic, GI upset(PO), neutropenia Notes: Not absorbed PO, local effect in gut only; give IV doseslowly (over 1–3 h) to prevent “red-man synd” (flushing of head/neck/upper torso);IV product PO for colitis; Levels: Peak: 1 h after inf; Trough < 0.5 h before nextdose; Therapeutic: Peak 30–40 mcg/mL, Trough < 2 mcg/mL; Toxic Peak > 50mcg/mL, Trough > 15 mcg/mL; 1 ⁄2 life: 6–8 hVardenafil (Levitra) WARNING: May prolong QT c interval Uses:*ED* Action: PDE5 inhibitor, increases cGMP and NO levels; Relaxes smoothmuscles, dilates cavernosal arteries Dose: 10 mg PO 60 min before sexual activity;2.5 mg if administered w/ CYP3A4 inhibitors (Table 11); max × 1 ≤20 mg Caution:[B, –] W/ CV, hepatic, or renal Dz Contra: Nitrates, ↑ Qtc interval Disp:Tabs 2.5, 5, 10, 20 mg tabs SE: ↓ BP, HA, dyspepsia, priapism hearing loss Notes:Concomitant α-blockers may cause ↓ BPVarenicline (Chantix) Uses: *Smoking cessation* Action: Nicotine receptorantagonist Dose: Adults. 0.5 mg PO daily × 3 d, 0.5 mg bid × 4 d, then 1 mgPO bid for 12 wks total; after meal w/ glass of water Caution: [C,?/–] ↓ dosew/renal impair Disp: Tabs 0.5, 1 mg SE: N, V, insomnia, flatulence, unusualdreams Notes: Slowly ↑ dose to ↓ N; initiate 1 wk before desired smoking cessationdateVaricella Virus Vaccine (Varivax) Uses: *Prevent varicella (chickenpox)*Action: Active immunization; live attenuated virus Dose: Adults & Peds.0.5 mL SQ, repeat 4–8 wk Caution: [C, M] Contra: Immunocompromise;neomycin-anaphylactoid Rxn, blood dyscrasias; immunosuppressive drugs; avoidPRG for 3 mo after Disp: Powder for inj SE: Mild varicella Infxn; fever, localRxns, irritability, GI upset Notes: OK for all children & adults who have not hadchickenpox

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!